Interestingly, while acetylcholinesterase inhibitors can increase cognition and memory modestly in AD, they have been consistently unsuccessful in treating schizophrenia-related cognitive impairment [98, 99]. The gene discussed is ACHE; the disease is Alzheimer disease.